UCSF home page UCSF home page About UCSF UCSF Medical Center
UCSF navigation bar
photos

Faculty Profiles

Michele Tana, MD
M_MED-GAST-ZSFG
Assistant Professor

1001 Potrero Ave
San Francisco, CA 94110

Michele Tana grew up in Northern Virginia. She studied the Classics at Harvard College, then went to Harvard Medical School. She did her Internal Medicine training at Stanford University Hospital and Clinics and her gastroenterology fellowship at California Pacific Medical Center. She spent two years at the National Institutes of Health as a Clinical Fellow in the National Institute of Diabetes and Digestive and Kidney Diseases, Liver Diseases Branch, then joined the UCSF faculty at San Francisco General Hospital in 2013. She is a clinician-educator with an interest in clinical research.

Education and Training

Location Degree or Training Specialty Date
Duke University M.H.S. Clinical Research 2016
National Institutes of Health Hepatology NIDDK 2013
California Pacific Medical Center Gastroenterology Department of Medicine 2011
Stanford University Internal Medicine School of Medicine 2008
Harvard University M.D. Medical Schoool 2005
Harvard College A.B. Classics 2000

Interests

alcoholic liver disease, autoimmune hepatitis, fatty liver disease, gastrointestinal endoscopy, health disparities, health services research, medical education, mentoring, patient reported outcomes, primary biliary cirrhosis, underserved populations, viral hepatitis

Recent Articles (9)

Tana MM, Muir AJ. Diagnosing liver fibrosis and cirrhosis: Serum, imaging or tissue? Clin Gastroenterol Hepatol. 2017 Jul 07.

van Wijk XMR, Magee CA, Wu AHB, Tana MM, Lynch KL. A comparison of methods for evaluation of a case of suspected macro-aspartate aminotransferase. Clin Chim Acta. 2016 Dec 01; 463:1-3.

Ha J, Yan M, Aguilar M, Bhuket T, Tana MM, Liu B, Gish RG, Wong RJ. Race/ethnicity-specific disparities in cancer incidence, burden of disease, and overall survival among patients with hepatocellular carcinoma in the United States. Cancer. 2016 Aug 15; 122(16):2512-23.

Ha J, Yan M, Aguilar M, Tana M, Liu B, Frenette CT, Bhuket T, Wong RJ. Race/Ethnicity-specific Disparities in Hepatocellular Carcinoma Stage at Diagnosis and its Impact on Receipt of Curative Therapies. J Clin Gastroenterol. 2016 May-Jun; 50(5):423-30.

Tana MM, Shums Z, Milo J, Norman GL, Leung PS, Gershwin ME, Noureddin M, Kleiner DE, Zhao X, Heller T, Hoofnagle JH. The Significance of Autoantibody Changes Over Time in Primary Biliary Cirrhosis. Am J Clin Pathol. 2015 Oct; 144(4):601-6.

Tana MM, Zhao X, Bradshaw A, Moon MS, Page S, Turner T, Rivera E, Kleiner DE, Heller T. Factors associated with the platelet count in patients with chronic hepatitis C. Thromb Res. 2015 May; 135(5):823-8.

Tana MM, Heller T. Autoantibodies in hepatitis C: red flag or bystander effect? J Pediatr Gastroenterol Nutr. 2013 Mar; 56(3):243.

Tana MM, Hoofnagle JH. Scar undone: long-term therapy of hepatitis B. Lancet. 2013 Feb 09; 381(9865):433-4.

  Select data provided by UCSF Profiles, powered by CTSI at UCSF. Learn more about the data source.